Royal Philips
NYSE : PHG
AEX : PHI

Royal Philips

September 02, 2005 10:00 ET

Philips Launches New Cardiology Ultrasound System and Clinical Resources at European Society of Cardiology Meeting; System and technology innovation reinforce Philips leadership in cardiology

STOCKHOLM, Sweden--(CCNMatthews - Sep 2, 2005) -

Royal Philips Electronics (NYSE: PHG; AEX: PHI) today launched the new Philips HD11 XE cardiology ultrasound system to coincide with the first day of Europe's largest cardiology conference, the European Society of Cardiology, hosted in Stockholm. Seen for the first time by cardiologists worldwide, the system is the latest version of the popular HD11 ultrasound system with a flat panel monitor, and is designed to meet the specific needs of cardiologists through more powerful cardiac capabilities that allow advanced quantification to make faster and more specific treatment decisions.

Philips HD11 XE

The new Philips HD11 XE adds a variety of features to help physicians more accurately measure heart chambers, wall motion and ejection fraction. The system also features QLAB quantification software to help physicians improve their diagnostic capability by providing non-invasive assessment of cardiac anatomy and function, including:

-- Strain Quantification, using Tissue Doppler Imaging (TDI) provides tools to quantify velocity and evaluate patients for synchronization therapy

-- Automated intima media thickness (IMT) measurements of carotid and other superficial arteries

-- Region of Interest (ROI) quantification to analyze pixel intensities from 2D or colour Doppler data sets in up to 10 user-defined regions, and graph them over time

The Philips HD11 XE system was designed to meet the growing need of many healthcare institutions for a cardiovascular ultrasound system that can quickly handle the scanning needs of a widely divergent patient population and the increasing demand for echo examinations.

1,000th iE33 system shipped As of September 1, 2005 Philips Medical Systems has shipped more than 1,000 iE33 intelligent echocardiography systems throughout the world. The popular ultrasound system reached this key milestone less than eleven months after its introduction, in October 2004.

The Philips iE33 is a new generation of cardiac ultrasound equipment that uses high-definition imaging to help physicians better diagnose heart disease and incorporates data analysis tools to help support treatment decisions and monitor treatment success. Physicians around the world have praised the Philips iE33 for its extraordinary 2-D image quality, powerful 3-D measurement of cardiac function and anatomy, Live 3D imaging of the beating heart, and user-centric ergonomics. The iE33 system also offers a wide range of high-performance features including voice-activated control and automated image optimization technologies.

"The Philips iE33 is a demonstration of the expanding role of ultrasound in the management of cardiac patients. Now physicians have the tools to look at the heart beating in three dimensions and make a more accurate measure of heart function, in less than a minute." said Kurt Kelln, director, ultrasound, for Philips Medical Systems, Europe.

"The growing number of heart failure patients and the need for economical care solutions are a challenge for physicians. Our commitment to giving them what they need to more accurately diagnose, make treatment decisions and monitor treatment is reflected in the popularity of the iE33," said Barbara Franciose, CEO, ultrasound, for Philips Medical Systems.

Philips ST Map

ST Map is a new addition to the growing set of clinical decision support tools available on Philips IntelliVue patient monitors.

Continuous ST segment monitoring - the ST segment is the portion of the electrocardiographic tracing that can indicate myocardial ischemia, or less-than-normal blood flow to the heart. - is accepted as a sensitive detector of myocardial ischemia. However, standard tabular displays of the data can be difficult for clinicians to interpret. Philips new ST Map graphical display is designed around the clinician. It displays a mind's-eye-view of ST segment changes, with the goal of helping clinicians recognize patterns and track patient progress more easily.

New QLAB Synchronicity Indices Software release

The unique capability of the Philips iE33 echocardiography system to accurately measure the wall motion in 17 different segments of the heart has been further enhanced with the addition of a 3D "synchronicity indices" that can help determine those patients who would best benefit from cardiac resynchronization therapy (the implantation of a pacemaker).

The indices, developed by leading cardiac physicians around the world, draw clinical data from scores of CRT cases to identify probable success scenarios. The QLAB software uses live three-dimensional data of the heart to measure and compare the time to maximum contraction of the left ventricle--a key indicator of heart health.

Philips products and technologies will be displayed at ESC booths,

For further information please contact:

Heidi Wilson

Tel: +1 978 659 7302

Heidi.Wilson@philips.com

Steve Kelly

Tel: +1 425 487 7479

Steve.Kelly@philips.com

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is one of the world's biggest electronics companies and Europe's largest, with sales of EUR 30.3 billion in 2004. With activities in the three interlocking domains of healthcare, lifestyle and technology and 159,700 employees in more than 60 countries, it has market leadership positions in medical diagnostic imaging and patient monitoring, color television sets, electric shavers, lighting and silicon system solutions. News from Philips is located at www.philips.com/newscenter.

Contact Information